Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity

Jul 2020  Jun 2020  May 2020  Apr 2020  Mar 2020  Feb 2020  Jan 2020  Dec 2019  Nov 2019  Oct 2019  Sep 2019  Aug 2019  Jul 2019  Jun 2019  May 2019  Apr 2019  Mar 2019  Feb 2019  Jan 2019  Dec 2018  Nov 2018  Oct 2018  Sep 2018  Aug 2018  Jul 2018  Jun 2018  May 2018  Apr 2018  Mar 2018  Feb 2018  Jan 2018  Dec 2017  Nov 2017  Oct 2017  Sep 2017  Aug 2017  Jul 2017  Jun 2017  May 2017  Apr 2017  Mar 2017  Feb 2017  Jan 2017  Dec 2016  Nov 2016  Oct 2016  Sep 2016  Aug 2016  Jul 2016  Jun 2016  May 2016  Apr 2016  Mar 2016  Feb 2016  Jan 2016  Dec 2015  Nov 2015  Oct 2015  Sep 2015  Aug 2015  Jul 2015  Jun 2015  

Notifications
The following Independence Blue Cross commercial policies have been posted prior to their effective date.
08.01.18c, Vedolizumab (Entyvio®)
Notification: 04/05/2017 | Effective: 05/05/2017 | Posted: 04/05/2017
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

11.03.05c, Frenectomy or Frenotomy for Ankylogossia (Tongue-Tie)
Notification: 04/06/2017 | Effective: 07/05/2017 | Posted: 04/06/2017
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update

12.01.01ak, Experimental/Investigational Services
Notification: 04/19/2017 | Effective: 07/18/2017 | Posted: 04/19/2017
Type of policy change: Coverage and/or Reimbursement Position

08.00.25i, Treatment of Pulmonary Artery Hypertension with Intravenous, Subcutaneous, and Inhaled Pharmacologic Agents
Notification: 04/26/2017 | Effective: 05/26/2017 | Posted: 04/26/2017
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update


New Policies
The following commercial policies have been newly developed to communicate coverage and/or reimbursement positions, reporting requirements, and other processes and procedures for doing business with Independence Blue Cross
06.02.55, Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, or Antiepileptics
Notification: 03/08/2017 | Effective: 04/07/2017 | Posted: 04/07/2017
Type of policy change: This is a new policy.

08.01.36, Nusinersen (Spinraza™)
Effective: 04/19/2017 | Posted: 04/19/2017
Type of policy change: This is a new policy.


Reissue Policies
The following commercial policies have been reviewed, and no substantive changes were made.
11.06.09c, Labiaplasty
Reissue Effective: 03/29/2017 | Reissue Posted: 04/07/2017

11.11.05e, Circumcision
Reissue Effective: 04/12/2017 | Reissue Posted: 04/13/2017

07.13.05i, Photodynamic Therapy (PDT) Using Verteporfin (Visudyne®)
Reissue Effective: 04/12/2017 | Reissue Posted: 04/13/2017

08.01.24, Deoxycholic Acid (Kybella™)
Reissue Effective: 04/26/2017 | Reissue Posted: 04/26/2017


Coding Update
The following commercial policies have been reviewed and updated to add new and revised medical codes (e.g., ICD-9 and ICD-10 diagnosis codes; CPT® and HCPCS codes; revenue codes) and/or remove terminated medical codes.
00.10.41b, Telemedicine for Primary Care Services (Independence)
Effective: 01/02/2017 | Posted: 04/28/2017


Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.